Want to join the conversation?
$EMN took actions during 4Q15 to reduce its non-operations workforce resulting in restructuring charges of $51MM for severance. The company anticipates annual total cost savings of approx. $55MM, mainly SG&A expenses and cost of sales, beginning in 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.